|1.||Zeng, Huihui: 4 articles (01/2011 - 09/2003)|
|2.||Ross, Brian M: 3 articles (03/2011 - 10/2003)|
|3.||Tan, Qiang: 3 articles (01/2011 - 01/2008)|
|4.||Li, Jing: 3 articles (01/2011 - 01/2008)|
|5.||Zhao, Fang: 3 articles (06/2010 - 01/2007)|
|6.||Kharitonov, S A: 3 articles (10/2000 - 04/2000)|
|7.||Paredi, P: 3 articles (10/2000 - 04/2000)|
|8.||Barnes, P J: 3 articles (10/2000 - 04/2000)|
|9.||Glen, Iain: 2 articles (03/2011 - 10/2003)|
|10.||Zeng, Hui-hui: 2 articles (06/2010 - 11/2003)|
02/01/2008 - "Carbohydrate and ethane release with Erwinia carotovora subspecies betavasculorum--induced necrosis."
05/01/1980 - "Lipid peroxidation was measured by determining ethane production rates of intact animals; toxicity was assessed by survival and by histological and serum enzyme evidence of liver and kidney necrosis. "
09/30/1979 - "Ethane production and liver necrosis in rats after administration of drugs and other chemicals."
02/01/2008 - "The release of carbohydrates and ethane from potato tuber slices inoculated with the soft rot necrosis-causing Erwinia was significantly greater than that of potato tuber slices that had not been inoculated or that had been inoculated with the nonpathogenic E. "
02/01/2008 - "carotovora strain and two avirulent strains, a Citrobacter sp. and an Enterobacter cloacae, was examined using digital analysis of photographic evidence of necrosis as well as for carbohydrate, ethane, and ethylene release compared with uninoculated potato tuber slices. "
|2.||Body Weight (Weight, Body)
04/01/1990 - "An adrenal blocker, 1,1dichloro-2,2-bis/p-chlorophenyl/ethane, was most effective when given intramuscularly, at a dose rate of 16 or 14 mg/kg of body weight, the technical or reagent chemical, respectively (P<0.001). "
09/01/2004 - "injection of ethane dimethanesulphonate (EDS) in a dose of 75 mg/kg body weight. "
07/01/2003 - "Breath samples were collected after patients had breathed purified air for 4 min, and ethane content was measured by GC and expressed as pmoles/kg-body weight-minute (pmol/kg-min). "
11/01/1995 - "We investigated whether Wistar rats of different body weights (BW: 78 +/- 6, 121 +/- 12 and 347 +/- 30 g) and hence different metabolic rates per unit weight, expire different amounts of ethane. "
11/01/1995 - "Assessment of lipid peroxidation in rats of different body weight by determining expired ethane."
05/01/1990 - "Maximal amounts of expired ethane and pentane were significantly higher for patients with a poor outcome (five deaths, six cases of bronchopulmonary dysplasia) than for those with good outcome (eight infants surviving intact) (p less than 0.01). "
07/01/1994 - "Infants with high maximum expired ethane and pentane (exceeding 40 pmol x kg-1 x min-1) had higher odds of dying or having bronchopulmonary dysplasia than those with low ethane and pentane (odds ratio, 6.5; 95% confidence interval, 1.1 to 38.5; p < 0.05 for ethane and odds ratio, 5.6; 95% confidence interval, 1.1 to 29.3; p < 0.05 for pentane). "
12/01/1997 - "In recent years a body of data has accumulated, linking the development of bronchopulmonary dysplasia (BPD) to increased oxidative stress in the first few days after birth, since high concentrations of metabolites reflecting increased peroxidation products such as pentane, ethane, protein carbonyl, o-tyrosine, allantoin and F2-isoprostanes, as well as low levels of glutathione and sulfhydryl/total protein ratio, also reflecting increased oxidative load, have been found in the premature infants at risk of or developing BPD. "
07/16/1986 - "Lipid peroxidation activity was determined in liver microsomes, hepatocytes and cultured granuloma cells by measuring ethane and pentane production with an improved capillary gas chromatographic method. "
05/01/1991 - "PUFA deficiency in inflamed rats gave rise to a lower inflammatory response (granuloma weight and prostaglandin E2 concentration) and ethane exhalation. "
01/01/1985 - "This case is of interest from 3 points of view: haematological: the simultaneous occurrence of hypercalcaemia (4.80 mmol/l) and of a leukaemic phase (19,300 lymphocytes/mm3) with no signs of "transformation" of the haemopathy; physiopathological: increased osteoclastic bone resorption and a rise in serum parathormone (0.21 to 4.82 ng/ml); therapeutic: efficacy of oral ethane 1, hydroxy 1, 1 diphosphonate (20 mg/kg/day) in treating the hypercalcaemia."
02/01/2013 - "The first-generation bisphosphonate etidronate (EHDP; ethane-1-hydroxy-1,1-diphosphonic acid, also known as 1-hydroxyethylidene-bisphosphonate) inhibits bone resorption and can mimic endogenous inorganic pyrophosphate by blocking mineralization. "
|2.||Parathyroid Hormone (Parathormone)
|5.||Etidronic Acid (HEDP)
|6.||Dichlorodiphenyl Dichloroethylene (DDE)
|10.||Glutamic Acid (Glutamate)
|1.||Cardiopulmonary Bypass (Heart-Lung Bypass)